Huons Global Overview
- Year Founded
-
1965
- Status
-
Public
- Employees
-
123
- Stock Symbol
-
084110
- Investments
-
30
- Share Price
-
$14.56
- (As of Friday Closing)
Huons Global General Information
Description
Huons Global Co Ltd is active in the healthcare sector. Its primary business includes the manufacture and sale of pharmaceutical products. The main business areas of the company are total healthcare businesses, including pharmaceuticals, biopharmaceutical research and development, aesthetics, medical devices, and health functional foods.
Contact Information
Website
www.huons.comCorporate Office
- 8th Floor HuonsGlobal Building
- A-dong Pangyo I-Square, 7, Changeop-ro, Sujeong-gu
- Seongnam, Gyeonggi 13449
- South Korea
Corporate Office
- 8th Floor HuonsGlobal Building
- A-dong Pangyo I-Square, 7, Changeop-ro, Sujeong-gu
- Seongnam, Gyeonggi 13449
- South Korea
Huons Global Stock Performance
As of 13-Nov-2026, Huons Global’s stock price is $14.56. Its current market cap is $178M with 12.2M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $14.56 | $14.53 | $13.40 - $52.00 | $178M | 12.2M | 36.7K | $1.28 |
Huons Global Financials Summary
As of 30-Jun-2026, Huons Global has a trailing 12-month revenue of $583M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 544,882 | 779,487 | 652,618 | 460,944 |
| Revenue | 583,484 | 595,482 | 596,188 | 580,045 |
| EBITDA | 88,822 | 109,405 | 96,524 | 119,449 |
| Net Income | 15,557 | 20,264 | 18,902 | 29,358 |
| Total Assets | 997,400 | 1,083,269 | 954,499 | 1,022,725 |
| Total Debt | 192,184 | 213,374 | 201,896 | 191,562 |
Huons Global Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Huons Global Patents
Huons Global Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026182539-A1 | Oral pharmaceutical formulation comprising glp-1 agonist, and preparation method therefor | Pending | 26-Feb-2025 | ||
| JP-2026519325-A | A transparent complex eye drop containing a carbonic anhydrase inhibitor and timolol, and a method for producing the same. | Pending | 13-May-2024 | ||
| WO-2025239614-A1 | Transparent composite eye drop containing carbonic anhydrase inhibitors and timolol and preparation method therefor | Pending | 13-May-2024 | ||
| JP-2026532257-A | Novel imidazopyridine compounds, and compositions containing the compound as an active ingredient for the prevention, improvement, or treatment of gastrointestinal inflammatory diseases or gastric acid-related diseases. | Pending | 15-Sep-2023 | ||
| AU-2024342965-A1 | Novel imidazopyridine-based compound and composition comprising same as active ingredient for preventing, alleviating, or treating gastrointestinal inflammatory diseases or gastric acid-related diseases | Pending | 15-Sep-2023 | A23L33/10 |
Huons Global Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Huons Global Investments & Acquisitions (30)
Huons Global’s most recent deal was a Later Stage VC with Arkgen Bioscions for . The deal was made on 13-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Arkgen Bioscions | 13-Jul-2026 | Later Stage VC | Drug Discovery | ||
| Bio Rosette | 17-Nov-2025 | Merger/Acquisition | BPO/Outsource Services | ||
| PanGen Biotech | 12-May-2025 | PIPE | Pharmaceuticals | ||
| PanGen Biotech | 19-Dec-2024 | PIPE | Pharmaceuticals | ||
| Medithings | 03-Jun-2024 | Early Stage VC | Monitoring Equipment |
Huons Global ESG
Risk Overview
Risk Rating
Updated September, 30, 2025
33.94 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,999
Rank
Percentile
Pharmaceuticals
Industry
of 952
Rank
Percentile
Pharmaceuticals
Subindustry
of 438
Rank
Percentile
Huons Global Exits (8)
Huons Global’s most recent exit was on 26-Oct-2023 from CellBion. The exit was categorized as with 11 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CellBion | 26-Oct-2023 | Completed |
|
||
| IMGT | 17-Dec-2021 | Completed |
|
||
| IMGT | 30-Nov-2020 | Completed |
|
||
| Medihub (Medical Supplies) | 18-Jun-2020 | Completed |
|
||
| EOFlow | 04-May-2018 | Later Stage VC | Completed |
|
Huons Global Affiliates
Subsidiaries (7)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Food Assemble | Seoul, South Korea | 2018 | |
| HuonsLifeSciences | Seongnam-si, South Korea | 2015 | |
| Humedix | Seongnam, South Korea | 2002 | |
| HuM&C | Incheon, South Korea | 2002 | |
| Huon N | Geumsan-gun, South Korea | 2001 |
Huons Global FAQs
-
When was Huons Global founded?
Huons Global was founded in 1965.
-
Where is Huons Global headquartered?
Huons Global is headquartered in Seongnam, South Korea.
-
What is the size of Huons Global?
Huons Global has 123 total employees.
-
What industry is Huons Global in?
Huons Global’s primary industry is Holding Companies.
-
Is Huons Global a private or public company?
Huons Global is a Public company.
-
What is Huons Global’s stock symbol?
The ticker symbol for Huons Global is 084110.
-
What is the current stock price of Huons Global?
As of 13-Nov-2026 the stock price of Huons Global is $14.56.
-
What is the current market cap of Huons Global?
The current market capitalization of Huons Global is $178M.
-
What is Huons Global’s current revenue?
The trailing twelve month revenue for Huons Global is $583M.
-
What is Huons Global’s annual earnings per share (EPS)?
Huons Global’s EPS for 12 months was $1.28.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
